Dataset Information


Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.

ABSTRACT: Respiratory syncytial virus (RSV) is the most common cause of infant hospitalizations and severe RSV infections are a significant risk factor for childhood asthma. The pathogenic mechanisms responsible for RSV induced immunopathophysiology remain elusive. Using an age-appropriate mouse model of RSV, we show that IL-33 plays a critical role in the immunopathogenesis of severe RSV, which is associated with higher group 2 innate lymphoid cells (ILC2s) specifically in neonates. Infection with RSV induced rapid IL-33 expression and an increase in ILC2 numbers in the lungs of neonatal mice; this was not observed in adult mice. Blocking IL-33 with antibodies or using an IL-33 receptor knockout mouse during infection was sufficient to inhibit RSV immunopathogenesis (i.e., airway hyperresponsiveness, Th2 inflammation, eosinophilia, and mucus hyperproduction); whereas administration of IL-33 to adult mice during RSV infection was sufficient to induce RSV disease. Additionally, elevated IL-33 and IL-13 were observed in nasal aspirates from infants hospitalized with RSV; these cytokines declined during convalescence. In summary, IL-33 is necessary, either directly or indirectly, to induce ILC2s and the Th2 biased immunopathophysiology observed following neonatal RSV infection. This study provides a mechanism involving IL-33 and ILC2s in RSV mediated human asthma.


PROVIDER: S-EPMC4608776 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3656337 | BioStudies
2010-01-01 | S-EPMC3063095 | BioStudies
2017-01-01 | S-EPMC5310870 | BioStudies
2017-01-01 | S-EPMC5484710 | BioStudies
2018-01-01 | S-EPMC6003836 | BioStudies
2014-01-01 | S-EPMC4149890 | BioStudies
2020-01-01 | S-EPMC7316593 | BioStudies
2020-01-01 | S-EPMC7312993 | BioStudies
2017-01-01 | S-EPMC5531601 | BioStudies
2020-01-01 | S-EPMC7044202 | BioStudies